DUBLIN, July 18, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Global Endometriosis Drugs Market 2016-2020" report to their offering.
The report forecasts the global endometriosis market to grow at a CAGR of 2.05% during the period 2016-2020.
The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
A trend boosting market growth is the increased focus on IUDs. Current treatment for endometriosis includes the use of GnRH agonists and oral contraceptives along with the use of surgeries. However, all these therapies are associated with many unwanted side effects due to hormonal changes in the body along with the early recurrence of the disease. Hence, the need for an effective replacement for these conventional therapies has led to the development of IUDs.
According to the report, a key growth driver is the increased adoption of OCPs. Apart from being used as contraceptives, these hormone pills are found to be effective in treating endometriosis. They do not cure endometriosis but are helpful in controlling the pain and preventing the condition from worsening. These medicines are also found to lower the chances of getting endometrial and ovarian cancer, ovarian cysts, certain breast lumps, and also protects the individual from osteoporosis.
Further, the report states that one challenge that could hamper market growth is surgery as the primary treatment option.
- Bayer HealthCare
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Market research methodology
PART 04: Introduction
PART 05: Pipeline analysis
PART 06: Key buying criteria for endometriosis drugs
PART 07: Market landscape
PART 08: Market segmentation by type of therapy
PART 09: Market segmentation by ROA
PART 10: Geographical segmentation
PART 11: Market drivers
PART 12: Impact of drivers
PART 13: Market challenges
PART 14: Impact of drivers and challenges
PART 15: Market trends
PART 16: Vendor landscape
PART 17: Key vendor analysis
PART 18: Appendix
For more information visit http://www.researchandmarkets.com/research/jbvwmz/global
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/global-endometriosis-drugs-market-to-grow-205---increased-focus-on-intrauterine-devices-iuds---research-and-markets-300299821.html
SOURCE Research and Markets